March 13 (Reuters) - Some U.S. stocks on the move on Wednesday: (For more market insights, including options activity, click on ; for The Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/faq23t)
U.S. stocks edged lower on Wednesday as investors paused after a recent rally, despite data showing retail sales rose more than expected in February.
The Dow Jones industrial average dropped 31.72 points, or 0.22 percent. The Standard & Poor’s 500 Index lost 3.03 points, or 0.20 percent. The Nasdaq Composite Index shed 10.03 points, or 0.31 percent.
** SPECTRUM PHARMACEUTICALS, $7.85, down 37 pct (0946 ET)
The company forecast a steep drop in full-year sales as it expects uptake of its biggest-selling product, colon cancer drug Fusilev, to significantly decline as cheaper generics re-enter the market.
** VELTI PLC, $2.21, down 30 pct (0946 ET)
The mobile marketing company reported a fourth-quarter profit well below analysts’ expectations on Tuesday, and said it had decided to forego a “significant amount” of additional business in Greece, the Balkan and other regions. It also said it expected to cut its capital expenditure by more than half.
** SYNERGETICS USA INC, $3.90, down 23 pct (1042 ET)
The company posted quarterly results that missed Wall Street estimates as sales decreased across all its business segments, while the cost of sales increased.
Wunderlich Securities downgraded Synergetics’ stock to a “hold” from a “buy”, and cut its price target on the company’s stock to $5.50 from $8.00.
** NATIONAL FINANCIAL PARTNERS, $22.87, up 14 pct (0941 ET)
The New York-based wealth management company headed by Sandy Weill’s daughter Jessica Bibliowicz is exploring a potential sale, according to three people familiar with the matter.
** MEMC ELECTRONIC MATERIALS INC, $4.79, down 12 pct (1109 ET)
The silicon wafer maker said sales of its solar energy systems would fall in the first quarter from the fourth. MEMC estimated it would sell 10 to 38 megawatts (MW) of solar energy systems in the first quarter ending March 31 on an adjusted basis. It sold 91 MW in the fourth quarter. [ID: nL3N0C52GE]
** ASM INTERNATIONAL NV, $34.95, down 13 pct (0943 ET)
The Dutch semiconductor equipment maker is selling a smaller-than-expected stake in its Hong Kong-listed unit, disappointing investors who had hoped a break-up of the firm might create more value for shareholders.
** BG MEDICINE INC, $2.02, up 11 pct (0945 ET)
The diagnostic test maker reported a smaller-than-expected fourth-quarter loss, helped by higher revenue from Galectin-3 - its blood test for use in patients with chronic heart failure.
** EXPRESS INC, $17.03, down 10 pct (0945 ET)
The apparel and accessories retailer said it was off to a slow start in the current quarter, hurt by a slowdown in consumer spending, after revamped promotions and merchandise helped it post strong fourth-quarter results.
** CAESARS ENTERTAINMENT CORP, $15.52, up 8 pct (1108 ET)
Morningstar Inc analyst Chad Mollman said the casino operator’s stock rose following a mention on Jim Cramer’s Mad Money show on CNBC. Based on the company’s weekly charts, Bob Lang, founder and senior strategist at ExplosiveOptions.net, believes the stock could surge to $20, Cramer said.
Cramer also said Caesars is expected to benefit from traffic growth in Las Vegas and the legalization of online gaming in New Jersey and Nevada. Caesars has the largest Las Vegas presence among publicly traded gaming companies.
** IMRIS INC, $3.32, down 7 pct (1035 ET)
The medical device company priced a public offering of 5.75 million of its common shares at $3.50 per share.
IMRIS said it intends to use the net proceeds for working capital and general corporate purposes, including commercialization of new products, and research and development.
** SUNESIS PHARMACEUTICALS INC, $5.76, up 7 pct (1053 ET)
The company reported fourth-quarter revenue which handily beat analysts’ estimates. Chief Executive Daniel Swisher said in a statement that the company was well funded to complete a late-stage trial of its cancer drug vosaroxin and to prepare for regulatory and pre-launch activities of the drug.
** MELLANOX TECHNOLOGIES, $61.62, down 6 pct (0944 ET)
A vice president and a director at the Israeli chip designer disclosed that they had sold shares of the company.
** GENMARK DIAGNOSTICS INC, $11.72, up 6 pct (0939 ET)
The company reported a smaller-than-expected fourth-quarter loss, helped by higher sales of its molecular diagnostic tests.
** DREAMWORKS ANIMATION SKG INC, $18.50, up 5 pct (1012 ET)
Stifel Nicolaus & Co raised the movie studio’s stock to a “hold” from a “sell”, saying the impact of a $87 million write-down due to the weak box office performance of its movie “Rise of the Guardians” has largely played out.
** VMWARE INC, $79.00, up 5 pct (0955 ET)
** EMC CORP, $24.73, up 1 pct (0955 ET)
The data storage equipment maker plans to create a new company called Pivotal that would be 69 percent owned by EMC and 31 percent owned by its publicly traded affiliate VMware, according to EMC Chief Executive Joe Tucci.
** GAIN CAPITAL HOLDINGS INC, $4.13, down 5 pct (1005 ET)
The company, which provides online foreign exchange trading services, reported a wider quarterly loss as revenue in its retail over-the-counter (OTC) business fell.
** VALERO ENERGY CORP, $43.31, down 5 pct (1012 ET)
The refiner was downgraded by Macquarie analysts to a “neutral” rating from an “outperform” rating, according to theflyonthewall.com.
** KRATOS DEFENSE AND SECURITY SOLUTIONS INC, $4.25, down 5 pct (0942 ET)
The defense contractor forecast 2013 revenue below analysts’ expectations, citing uncertainty due to U.S. budget cuts.
** DOLE FOOD CO INC, $11.15, down 5 pct (0939 ET)
The fruit and fresh vegetable distributor reported fourth-quarter results that missed market estimates due to challenging banana market conditions and one-time charges.
** WALGREEN CO, $42.66, up 4 pct (1102 ET)
UBS Securities upgraded the U.S.’ largest drug retailer to a “buy” rating, saying it sees a buying opportunity in the stock which is off its highs in recent days. It also cited positive developments at the company, which include its Alliance Boots deal, and possible benefits from health reform in 2014.
The brokerage also raised its full-year EPS estimates as it expects stronger gross margins in 2013 due to restrained promotions.
** HECKMANN CORP, $4.33, up 4.5 pct (1041 ET)
The wastewater management company posted a profit on Monday, boosted by its merger with Power Fuels and growth in its legacy Heckmann Water Resources business.
The company also said expects revenue to more than double to between $750 million and $825 million.
** ANNIE‘S INC, $39.66, down 4 pct (1038 ET)
The organic food maker, known for its bunny mascot, said it had priced its secondary offering of 3.5 million common shares at $40 per share.
** FLAGSTAR BANCORP, $14.35, down 4 pct (0954 ET)
Compass Point started the Midwestern lender will a ‘sell’ rating, Benzinga.com reported.
** NETFLIX INC, $189.07, up 4 pct (1000 ET)
The video service unveiled a new feature on Wednesday that allows subscribers to let their Facebook Inc friends know what television shows and movies they are watching and also see friends’ viewing activity.
** ICICI BANK LTD , $42.95, down 3 pct (1010 ET)
Interest rate-sensitive stocks such as ICICI Bank retreated a day before key inflation data that could help determine whether the central bank would ease monetary policy.
** FORTRESS INVESTMENT GROUP $6.89, up 3 pct (1003 ET)
Goldman Sachs raised the alternative asset manager to a ‘buy’ rating, Streetinsider.com reported.
** EAGLE ROCK ENERGY PARTNERS LP, $9.31, down 3 pct (0939 ET)
The company, which transports natural gas and associated liquids, said it would sell 8 million common units and use the proceeds to repay a portion of its debt. (Compiled by Pallavi Ail in Bangalore; Editing by Sreejiraj Eluvangal)